Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K033998
    Manufacturer
    Date Cleared
    2004-03-19

    (86 days)

    Product Code
    Regulation Number
    870.2700
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    MASIMO SET RAD-5V PULSE OXIMETER, MODEL RAD-5V

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Masimo SET® Rad-5v Pulse Oximeter is intended for non-continuous noninvasive monitoring of finctional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate (measured by an SpO3 sensor) for adult, pediatric, and neonatal patients in hospitals, hospital-type facilities, and mobile environments.

    The Rad-5v Handheld Pulse Oximeter is indicated for the non-continuous noninvasive monitoring of functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate (measured by an SpO2 sensor) for adult, pediatric, and neonatal patients during both motion conditions, and for patients who are well or poorly perfused in hospitals, hospital-type facilities, and mobile environments.

    The Masimo SET® Rad5v Pulse Oximeter is indicated for the non-continuous noninvasive monitoring of functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate (measured by an SpO2 sensor) for adult, pediatric, and neonatal patients during both no motion and motion conditions, and for patients who are well or poorly perfused in hospital-type facilities, mobile, and home environments.

    Device Description

    The Masimo SET® Rad-Sv Handheld Pulse Oxineter is noninvasive, arterial oxygen saturation and pulse rate monitor. The Rad-ITIC Mannin SEE - Not of Principely that continuously displays numeric values for SpO2 and pulse rate, as well as LED indicator bars for Pulse Amplitude Index (PAI) and Signal Quality (SQ).

    AI/ML Overview

    Here's an analysis of the acceptance criteria and the studies that prove the Masimo SET® Rad-5v Pulse Oximeter meets them, based on the provided text:

    1. Table of Acceptance Criteria and Reported Device Performance

    ParameterAcceptance Criteria (from Specifications and Operating Ranges & Notes 1-4)Reported Device Performance (from K033998 510(k) Summary and Clinical Tests)
    Saturation (% SpO2) - No Motion
    Adults, Pediatrics70% - 100% ± 2 digits± 2 digits (against co-oximeter)
    Neonates70% - 100% ± 3 digits± 3 digits (against co-oximeter)
    Saturation (% SpO2) - Motion
    Adults, Pediatrics70% - 100% ± 3 digits± 3 digits (against co-oximeter)
    Neonates70% - 100% ± 3 digits± 3 digits (against co-oximeter)
    Pulse Rate (bpm) - No Motion
    Adults, Pediatric, Neonates25 to 240 ± 3 digits± 3 digits (against ECG)
    Pulse Rate (bpm) - Motion
    Adults, Pediatric, Neonates25 to 240 ± 5 digits± 5 digits (against ECG)
    Low Perfusion Performance
    Saturation (% SpO2)± 2 digits (for > 0.02% Pulse Amplitude & > 5% Transmission)± 2 digits (against co-oximeter)
    Pulse Rate± 3 digits (for > 0.02% Pulse Amplitude & > 5% Transmission)± 3 digits (against ECG)

    Note: The "acceptance criteria" presented above are directly derived from the device's stated "Specifications and Operating Ranges" and the accompanying notes, which describe the validation methods and expected accuracy.

    2. Sample Size Used for the Test Set and Data Provenance

    The document does not explicitly state a numerical "sample size" for the test set in terms of the number of subjects or data points. However, it mentions:

    • Human Blood Studies on Healthy Adult Volunteers: Used for no motion and motion accuracy (induced hypoxia).
    • Clinical Studies on Neonates: Used for no motion conditions and low perfusion.
    • Bench Top Testing: Used for low perfusion accuracy against simulators.

    The data provenance is prospective human studies conducted as "clinical studies" and "human blood studies" as well as bench testing. The country of origin is not explicitly stated, but the company address is in Irvine, CA, USA, and the submission is to the US FDA, implying testing was likely conducted in the USA or under US regulations.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications

    The document does not specify the number of experts used to establish ground truth or their qualifications.

    4. Adjudication Method for the Test Set

    The document does not describe an adjudication method for the test set.

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

    There is no mention of a Multi-Reader Multi-Case (MRMC) comparative effectiveness study and therefore no effect size for human readers with and without AI assistance can be determined. Pulse oximetry is a direct measurement device, not typically requiring human interpretation of complex images or data in an MRMC study context.

    6. Standalone (Algorithm Only) Performance

    Yes, standalone performance was done. The entire testing described (bench testing and clinical studies against co-oximeters and ECG) establishes the algorithm's performance without specific human interpretation or intervention in the measurement process, other than device operation. The device continuously displays numeric values, implying an algorithmic output.

    7. Type of Ground Truth Used

    The ground truth used for the clinical and human blood studies was:

    • Arterial hemoglobin oxygen determined from arterial blood samples with a CO-Oximeter: For SpO2 accuracy.
    • ECG monitor: For pulse rate accuracy.

    For bench testing, the ground truth was provided by:

    • Brotek Index 2 simulator and Masimo's simulator: For low perfusion accuracy.

    8. Sample Size for the Training Set

    The document does not provide a sample size for the training set. It states that the "values in the look-up table are based upon human blood studies against a laboratory co-oximeters in induced hypoxia states during motion and non-motion conditions." This implies that data from human studies was used to develop or calibrate the device's algorithms (the look-up table), but the specifics of that dataset size are not detailed.

    9. How the Ground Truth for the Training Set Was Established

    The ground truth for the look-up table (which serves as the basis for the algorithm's calculation) was established by:

    • Human blood studies against a laboratory co-oximeter in induced hypoxia states during motion and non-motion conditions. The document indicates that the device's fundamental conversion algorithm from absorbance signals to SpO2 values is derived from these studies.
    Ask a Question

    Ask a specific question about this device

    K Number
    K033296
    Manufacturer
    Date Cleared
    2004-02-19

    (128 days)

    Product Code
    Regulation Number
    870.2700
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    MASIMO SET RAD-5 PULSE OXIMETER, MODEL RAD-5; MASIMO SET RAD-5V PULSE OXIMETER, MODEL RAD-5V

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Masimo SET® RAD-5 Pulse Oximeter is intended for continuous nonitoring of functional oxygen saturation of arterial hemoglobin (SpOz) and pulse rate (measured by an SpO2 sensor) for adult, pediatric, and neonatal patients in hospitals, hospital-type facilities, and mobile environments.

    The Rad-5 Handheld Pulse Oximeter is indicated for the continuous nonitoring of functional oxygen saturation of arterial hemoglobin (Sp() ) and pulse rate (measured by an SpO2 sensor). The Rad-5 Handheld Pulse Oximeter is indicated for use with adult, pediatric and neonatal patients during both motion conditions, and for patients who are well or poorly perfused in hospitals, hospital-type facilities, and mobile environments.

    The Masimo SET® Rad 5 Pulse Oximeter is indicated for the continuous nonitoring of functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate (measured by an SpO2 sensor). The Masimo SET® Rad 5 Pulse Oximeter is indicated for use with adult, pediatric, and neonatal patients during both no motion and ition conditions, and for patients who are well or poorly perfused in hospital-type facilities, mobile, and home environments.

    Device Description

    The Masimo SET® Rad-5 Pulse Oximeter is a handheld pulse oximeter that measures functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate. It utilizes spectrophotometry and plethysmography principles. The device displays SpO2, pulse rate, alarm status, alarm silenced status, Perfusion Index Bar, Signal IQ Bar, Battery Status, APOD, and FastSat. It has adjustable alarm volume and averaging settings. It is powered by 4 AA batteries.

    AI/ML Overview

    Here's an analysis of the acceptance criteria and study details for the Masimo SET® Rad-5 Pulse Oximeter, based on the provided text:


    Acceptance Criteria and Device Performance

    ParameterAcceptance Criteria (Study Endpoint)Reported Device Performance
    Saturation (% SpO2) - No Motion
    Adults, Pediatrics70% - 100% ± 2 digitsMet: within ± 2 digits (70%-100% range)
    Neonates70% - 100% ± 3 digitsMet: within ± 3 digits (70%-100% range, based on 83%-100% neonatal data combined with adult studies)
    Saturation (% SpO2) - Motion
    Adults, Pediatrics70% - 100% ± 3 digitsMet: within ± 3 digits (70%-100% range)
    Neonates70% - 100% ± 3 digitsMet: within ± 3 digits (70%-100% range, based on neonatal data combined with adult studies)
    Pulse Rate (bpm) - No Motion
    Adults, Pediatric, Neonates25-240 bpm ± 3 digitsMet: within ± 3 digits (25-240 bpm range)
    Pulse Rate (bpm) - Motion
    Adults, Pediatric, Neonates25-240 bpm ± 5 digitsMet: within ± 5 digits (25-240 bpm range)
    Low Perfusion PerformanceSpO2: ± 2 digits; Pulse Rate: ± 3 digits (for > 0.02% Pulse Amp & > 5% Transmission)Met: (implied by statement that technology was "validated for low perfusion accuracy")
    Environmental TestingPer Reviewers Guidance for Premarket Submissions - November 1993Met: All tests passed (electrical, mechanical, environmental)

    Study Details

    1. Sample sizes used for the test set and data provenance:

      • Test Set Sample Size: Not explicitly stated as a number of subjects. The studies were conducted on:
        • Healthy adult volunteers (for no motion, motion, and low perfusion conditions).
        • Neonates (for no motion, motion, and low perfusion conditions).
      • Data Provenance: The studies were described as "human blood studies" and were clinical tests. The location is not specified, but given the company is based in Irvine, CA, and the FDA approval process, they were likely conducted in the US. The studies are prospective, involving "induced hypoxia states."
    2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

      • Number of Experts: Not applicable. The ground truth was established by a laboratory co-oximeter and an ECG monitor, not human experts for interpretation.
      • Qualifications of Experts: N/A.
    3. Adjudication method for the test set:

      • Not applicable. The ground truth in this case is objective physiological measurements from a laboratory co-oximeter and an ECG monitor, not subjective interpretations requiring adjudication.
    4. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, if so, what was the effect size of how much human readers improve with AI vs without AI assistance:

      • No, an MRMC study was not done. This device is a standalone pulse oximeter, not an AI-assisted diagnostic tool that relies on human readers' interpretation.
    5. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:

      • Yes, this was a standalone performance study. The device's accuracy was directly compared against a physiological ground truth (co-oximeter and ECG) under various conditions. The device's algorithm performs the measurements and calculations independently to determine SpO2 and pulse rate.
    6. The type of ground truth used:

      • Clinical Ground Truth:
        • Co-Oximetry (Laboratory Co-Oximeter): Used to determine arterial hemoglobin oxygen saturation (SaO2) through arterial blood samples. This is considered the gold standard for oxygen saturation measurement.
        • Electrocardiogram (ECG Monitor): Used to determine true pulse rate.
    7. The sample size for the training set:

      • The document implies that the "values in the look-up table are based upon human blood studies against a laboratory co-oximeters in induced hypoxia states during motion and non-motion conditions." This suggests that a dataset of human blood studies was used to develop and refine the algorithm's look-up table. However, the specific sample size of this training set is not explicitly stated.
    8. How the ground truth for the training set was established:

      • As indicated in the "Principles of Operation" section, the "values in the look-up table" (which essentially represent the training data for the internal algorithm's calibration) were based on:
        • Human blood studies: Healthy adult volunteers were subjected to induced hypoxia states.
        • Comparison against a laboratory co-oximeter: Arterial blood samples were analyzed by a co-oximeter to provide the true oxygen saturation (SaO2) values.
        • This process was performed under both motion and non-motion conditions to build a robust look-up table for the device's internal calculations.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1